Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 22 Nov 2024 for Xenon Pharmaceuticals Inc., €25k. Read the official filing
Filing timeline
BuySaleGary Patou
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Gary Patou: trading record in brief
This profile gathers the share dealings of Gary Patou in Xenon Pharmaceuticals Inc., where the filings describe the role as board member. We count 6 filings; the first trade dates from 17 March 2021 and the latest from 22 November 2024.
The open-market record consists of 2 sales worth €355k, with no purchase. Other entries cover 3 option exercises.
Most recently, on 22 November 2024, the filings show an option exercise worth €25k in Xenon Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gary Patou
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
3,500 shares@ US$7.385.6% of flowCommon SharesSEC:0000950170-24-130378:0
6,378 shares@ US$9.8513.3% of flowCommon SharesSEC:0000950170-23-070841:0
7,598 shares@ US$41.0565.4% of flowCommon SharesSEC:0000950170-23-070912:0
2,057 shares@ US$34.326515.6% of flowCommon SharesSEC:0001209191-22-058916:0
2,057 shares@ US$3.6780.3% of flowCommon SharesSEC:0001209191-21-069018:0
100 shares@ US$19.4919.7% of flowCommon SharesSEC:0001209191-21-038431:0
6 of 6 declarations
